Officials warn that compounded semaglutide products can pose safety risks due to inconsistent dosing, lack of standardized testing, and potential ingredient issues
Semaglutide may influence the absorption of Adderall, possibly altering its effectiveness
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
Male mice exposed to CMS for 2 weeks showed increased pathogenic bacteria including Acinetobacter, Proteus , and Enterococcus (Tyagi et al., 2025)
And we think a lot of that was driven by less non-cardiovascular death, and that certainly would support other observations from the field
A concentration reported in one paper should be treated as a starting point, not as a universal protocol